These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22288900)

  • 1. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
    van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
    Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
    Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
    Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.
    Merli M; Lucidi C; Di Gregorio V; Giannelli V; Giusto M; Ceccarelli G; Riggio O; Venditti M
    Liver Int; 2015 Feb; 35(2):362-9. PubMed ID: 24836902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
    Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
    Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
    J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
    Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
    Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
    Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
    J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
    Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
    J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
    Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROTON PUMP INHIBITORS INCREASE THE OVERALL RISK OF DEVELOPING BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS.
    Lázaro-Pacheco IB; Servín-Caamaño AI; Pérez-Hernández JL; Rojas-Loureiro G; Servín-Abad L; Tijera FH
    Arq Gastroenterol; 2018; 55(1):28-32. PubMed ID: 29561973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS; Chen GH; Lien HC; Yeh HZ
    Hepatology; 1998 Nov; 28(5):1187-90. PubMed ID: 9794900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Ratelle M; Perreault S; Villeneuve JP; Tremblay L
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.